TABLE 1. GLOBAL INCIDENCE RATES OF DISEASES
TABLE 2. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 3. RADIOIMMUNOASSAY BASED IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. IMMUNOTURBIDITY ASSAY BASED IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. CHEMILUMINESCENCE ASSAY BASED IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. IMMUNOPROTEIN ELECTROPHORESIS BASED IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 7. ENZYME IMMUNOASSAY BASED IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. IMMUNOFLUORESCENCE ASSAY BASED IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR OTHER TECHNOLOGY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 11. C-REACTIVE PROTEIN DIAGNOSTIC TESTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. COMPLEMENT SYSTEM PROTEIN DIAGNOSTIC TESTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. PREALBUMIN DIAGNOSTIC TESTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14. HAPTOGLOBIN DIAGNOSTIC TESTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 15. IMMUNOGLOBULIN DIAGNOSTIC TESTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16. FREE LIGHT CHAIN DIAGNOSTIC TESTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. OTHER IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 19. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 20. INFECTIOUS DISEASES CAUSED BY SPECIFIC HOSTS
TABLE 21. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR INFECTIOUS DISEASES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. TYPES OF ALLERGY AND THEIR PREVALENCE
TABLE 23. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR ALLERGY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR ENDOCRINE DISEASES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 25. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR ONCOLOGY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR TOXICOLOGY TESTING, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 27. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 33. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 34. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 35. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 36. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 37. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 38. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 39. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 40. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 41. LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 42. LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 43. LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 44. LAMEA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 45. ABBOTT: COMPANY SNAPSHOT
TABLE 46. ABBOTT: OPERATING SEGMENTS
TABLE 47. ABBOTT: PRODUCT PORTFOLIO
TABLE 48. ABCAM: COMPANY SNAPSHOT
TABLE 49. ABCAM: OPERATING SEGMENTS
TABLE 50. ABCAM: OPERATING SEGMENTS
TABLE 51. BIO-RAD: COMPANY SNAPSHOT
TABLE 52. BIO-RAD: OPERATING SEGMENTS
TABLE 53. BIO-RAD: PRODUCT PORTFOLIO
TABLE 54. DANAHER: COMPANY SNAPSHOT
TABLE 55. DANAHER: OPERATING SEGMENTS
TABLE 56. DANAHER: PRODUCT PORTFOLIO
TABLE 57. DIOSORIN: COMPANY SNAPSHOT
TABLE 58. DIOSORIN: OPERATING SEGMENTS
TABLE 59. DIOSORIN: PRODUCT PORTFOLIO
TABLE 60. ENZO: SNAPSHOT
TABLE 61. ENZO: OPERATING SEGMENTS
TABLE 62. ENZO: PRODUCT PORTFOLIO
TABLE 63. ROCHE: COMPANY SNAPSHOT
TABLE 64. ROCHE: OPERATING SEGMENT
TABLE 65. ROCHE: PRODUCT PORTFOLIO
TABLE 66. ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 67. ORTHO CLINICAL DIAGNOSTICS: OPERATING SEGMENTS
TABLE 68. ORTHO CLINICAL DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 69. SIEMENS: COMPANY SNAPSHOT
TABLE 70. SEIMENS: OPERATING SEGMENTS
TABLE 71. SIEMENS: PRODUCT PORTFOLIO
TABLE 72. THERMO FISHER: COMPANY SNAPSHOT
TABLE 73. THERMO FISHER: OPERATING SEGMENTS
TABLE 74. THERMO FISHER: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 1. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023
FIGURE 2. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY, 2016-2023
FIGURE 3. MARKET SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS
FIGURE 5. TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 7. TOP PLAYER POSITIONING: IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016
FIGURE 8. INCIDENCE RATE OF CHRONIC DISEASES, 1995-2030
FIGURE 9. U.S. HEALTHCARE EXPENDITURE PER PERSON (USD)
FIGURE 10. RISING GDP OF MANY COUNTRIES ($TRILLION)
FIGURE 11. NUMBER OF DIAGNOSED CANCER CASES WORLDWIDE
FIGURE 12. GLOBAL COMMON CANCER STATISTICS, 2012-2030
FIGURE 13. SPECIFIC ILLICIT DRUG DEPENDENCE OR ABUSE IN THE U.S., 2013
FIGURE 14. U.S. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 16. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 17. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 18. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 19. UK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 20. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 21. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 22. REST OF EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 23. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 24. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 25. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 27. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 28. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 29. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, 2016-2023 ($MILLION)
FIGURE 30. ABBOTT: REVENUE, 2014-2016 ($MILLION)
FIGURE 31. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 32. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 33. ABCAM: REVENUE, 2014-2016 ($MILLION)
FIGURE 34. ABCAM: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 35. BIO-RAD: REVENUE, 2014-2016 ($MILLION)
FIGURE 36. BIO-RAD: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 37. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 38. DANAHER: REVENUE, 2014-2016 ($MILLION)
FIGURE 39. DANAHER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 40. DANAHER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 41. DIOSORIN: REVENUE, 2013-2015 ($MILLION)
FIGURE 42. DIOSORIN: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 43. ENZO: REVENUE, 2014-2016 ($MILLION)
FIGURE 44. ENZO: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 45. ENZO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 46. ROCHE: REVENUE, 2014-2016 ($MILLION)
FIGURE 47. ROCHE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 48. ROCHE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 49. SIEMENS: REVENUE, 2014-2016 ($MILLION)
FIGURE 50. SIEMENS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 51. SIEMENS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 52. THERMO FISHER: REVENUE, 2014-2016 ($MILLION)
FIGURE 53. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 54. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)